EP0568545A4 - Method of reducing elevated blood sugar levels in humans - Google Patents

Method of reducing elevated blood sugar levels in humans

Info

Publication number
EP0568545A4
EP0568545A4 EP19920901248 EP92901248A EP0568545A4 EP 0568545 A4 EP0568545 A4 EP 0568545A4 EP 19920901248 EP19920901248 EP 19920901248 EP 92901248 A EP92901248 A EP 92901248A EP 0568545 A4 EP0568545 A4 EP 0568545A4
Authority
EP
European Patent Office
Prior art keywords
humans
blood sugar
elevated blood
sugar levels
reducing elevated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920901248
Other versions
EP0568545A1 (en
Inventor
Joseph Larner
Alison Kennington
Laura C. Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia Patent Foundation
Original Assignee
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia Patent Foundation filed Critical University of Virginia Patent Foundation
Publication of EP0568545A1 publication Critical patent/EP0568545A1/en
Publication of EP0568545A4 publication Critical patent/EP0568545A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP19920901248 1991-01-23 1991-09-04 Method of reducing elevated blood sugar levels in humans Withdrawn EP0568545A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64463991A 1991-01-23 1991-01-23
US644639 1991-01-23

Publications (2)

Publication Number Publication Date
EP0568545A1 EP0568545A1 (en) 1993-11-10
EP0568545A4 true EP0568545A4 (en) 1993-11-24

Family

ID=24585768

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920901248 Withdrawn EP0568545A4 (en) 1991-01-23 1991-09-04 Method of reducing elevated blood sugar levels in humans

Country Status (5)

Country Link
EP (1) EP0568545A4 (en)
JP (1) JPH06504278A (en)
AU (1) AU662720B2 (en)
CA (1) CA2101775C (en)
WO (1) WO1992012706A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
US20010039297A1 (en) * 1998-05-19 2001-11-08 Insmed Pharmaceuticals, Inc. Compositions and method for improving insulin sensivity and glucose metabolism in individuals with impaired fasting glucose or impaired glucose tolerance
EP1183021A4 (en) 1999-05-20 2004-09-15 Humanetics Corp Stimulating transport of glucose into animal tissue by the administration of pinitol
US7250279B2 (en) 2000-04-07 2007-07-31 Merck Patent Gmbh Human pyruvate dehydrogenese phosphatase
JP4623996B2 (en) * 2004-04-21 2011-02-02 株式会社スリービー Antihypertensive agent containing tamogi mushroom extract as active ingredient
WO2013016741A1 (en) * 2011-07-22 2013-01-31 Smith Conrad Anton Dietary supplement for use in a weight loss program

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801597A (en) * 1985-06-11 1989-01-31 University Of Florida Certain inositol-nicotinate ester derivatives and polyionic complexes therefore useful for treating diabetes meuitus, hyperlipidemia and lactic acidosis
AU647735B2 (en) * 1989-03-08 1994-03-31 University Of Virginia Alumni Patents Foundation, The Dietary supplement for insulin-resistant diabetics
JPH04138126A (en) * 1990-09-29 1992-05-12 Tookai:Kk Shoes scrubbing mat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9212706A1 *

Also Published As

Publication number Publication date
AU662720B2 (en) 1995-09-14
EP0568545A1 (en) 1993-11-10
WO1992012706A1 (en) 1992-08-06
CA2101775A1 (en) 1992-07-24
CA2101775C (en) 1998-09-29
JPH06504278A (en) 1994-05-19
AU9056691A (en) 1992-08-27

Similar Documents

Publication Publication Date Title
ZA957800B (en) Therapeutic food composition and method to diminish blood sugar fluctuations
IL129467A0 (en) Therapeutic food composition and method to diminish blood sugar fluctuations
EP0497204A3 (en) Medical member and method of manufacturing the same
HU9602455D0 (en) Method of stimulating hematopoiesis with hemoglobin
AU2685892A (en) Method of treating blood
EP0568545A4 (en) Method of reducing elevated blood sugar levels in humans
GB9421287D0 (en) A method of reducing the level of sugar in an organism
BG95257A (en) Preparation and method for the treatment of paradontosis
GB9101175D0 (en) Method of treatment
GB9105617D0 (en) Method of treatment
GB9104267D0 (en) Method of treatment
GB9101176D0 (en) Method of treatment
GB9101001D0 (en) Method of treatment
GB9101000D0 (en) Method of treatment
IL90805A0 (en) Catheter and method of using same
KR0134034B1 (en) Treatment method
GB8812224D0 (en) Method of treatment
GB8816408D0 (en) Method of treatment
GB8808914D0 (en) Method of treatment
GB8808915D0 (en) Method of treatment
GB8811006D0 (en) Method of treatment
GB8811891D0 (en) Method of treatment
GB8803008D0 (en) Method of treatment
GB8822020D0 (en) Method of treatment
GB8822019D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930721

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19931006

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960401